Artlist, the leading AI platform for video creation, today announced the launch of a new category: AI Music. Artlist continues to empower creators with the most advanced AI tools, bringing professional-grade music creation directly into the video workflow. Integrating Google's latest state-of-the-art audio models, Lyria 3, and Lyria 3 Pro, the AI Music generators allow creators to generate origina...
Artlist, the leading AI platform for video creation, today announced the launch of a new category: AI Music. Artlist continues to empower creators with the most advanced AI tools, bringing professional-grade music creation directly into the video workflow. Integrating Google's latest state-of-the-art audio models, Lyria 3, and Lyria 3 Pro, the AI Music generators allow creators to generate original, studio-quality songs from simple text or up to 10 image prompts. The addition of AI Music expands
panumas nikomkai/iStock via Getty Images As the AI infrastructure buildout has progressed, the market has focused primarily on the likes of Nvidia ( NVDA ), AMD ( AMD ), and Micron ( MU ) - top semiconductor companies that produce the chips that drive cutting-edge AI models forward. Nvidia's top chips command tens of thousands apiece on the open market, and Micron has recently benefited from a mas...
panumas nikomkai/iStock via Getty Images As the AI infrastructure buildout has progressed, the market has focused primarily on the likes of Nvidia ( NVDA ), AMD ( AMD ), and Micron ( MU ) - top semiconductor companies that produce the chips that drive cutting-edge AI models forward. Nvidia's top chips command tens of thousands apiece on the open market, and Micron has recently benefited from a massive shortage in the memory space. What often gets overlooked are the cables that tie AI data centers together. Fast chips are good, but they're only as good as their ability to talk to other pieces of the cluster. Enter Credo Technologies ( CRDO ). As a leading seller of AECs, or "Active Electrical Cables," the firm has been a direct beneficiary of the recent data center buildout. The company's products allow for efficient data center optimization - especially over short distances - and revenue is up 6x over the last two years. However, following the company's most recent Q3 earnings report (when management announced that sales were up 201% year-over-year), the stock sold off nearly 20%. Why? A perceived deceleration in Credo's growth story. On the call, management expressed that forward revenue growth for fiscal year 2027 would "only" be in the ~50% range. This recent loss compounds with poor year-to-date performance of -30%. All told, I view this dip as a massive gift from the market. With top and bottom line results set to expand rapidly over the next few years - especially as new products expand the total addressable market - the business is set up to produce significant appreciation for investors. Trading at a reasonable price versus itself and key peers, I'm anticipating 30%+ annualized total returns through the end of the decade. Today, I'll break down the company's prospects, touch on the valuation, and make the case that this recent dip in CRDO is a huge opportunity that you should take advantage of. Financials In case you haven't heard of Credo before, as I just ...
Bubbers13/iStock via Getty Images DFEV Strategy DFA Dimensional Emerging Markets Value ETF ( DFEV ) is an actively managed fund launched on 04/27/2022. DFEV has 3463 holdings, a 12-month trailing yield of 2.55%, and a net expense ratio of 0.43%. Distributions are paid quarterly. As described in the prospectus by Dimensional , the fund essentially selects stocks based on valuation, but other factor...
Bubbers13/iStock via Getty Images DFEV Strategy DFA Dimensional Emerging Markets Value ETF ( DFEV ) is an actively managed fund launched on 04/27/2022. DFEV has 3463 holdings, a 12-month trailing yield of 2.55%, and a net expense ratio of 0.43%. Distributions are paid quarterly. As described in the prospectus by Dimensional , the fund essentially selects stocks based on valuation, but other factors are considered, in particular size and profitability. Value is primarily measured by the price-to-book value ratio, with secondary metrics such as price-to-cash-flow and price-to-earnings. Profitability is primarily measured by earnings or profits from operations in relation to book value or assets. Nonetheless, metrics used to assess value and profitability may change over time. The portfolio turnover rate was 14% in the most recent fiscal year. I will use the iShares MSCI Emerging Markets ETF ( EEM ) as a benchmark. Portfolio DFEV has about 69% of its asset value in large- and mega-cap companies. The top four countries in the portfolio are China (25.1%), Taiwan (20.8%), South Korea (18.9%), and India (14%). Other countries are below 5%. The geographical allocation is close to that of EEM, as plotted below. DFEV top countries (chart: author; data: Dimensional, iShares) The presence of South Korea and Taiwan among emerging markets is debatable. South Korea has been considered a developed country by S&P since 2001, and was surpassed by Taiwan in GDP per capita in 2025 . Both countries are ahead of the E.U., the U.K., and Japan in GDP at purchasing power parity per capita . The fund has significant exposure in financials (26.4%) and technology (22%). Compared to EEM, DFEV significantly downplays technology and communication services. DFEV sector breakdown (chart: author; data: Dimensional, iShares) Company-specific risk is low to moderate, with about 17% of asset value in the top 10 holdings (listed in the next table) and 4% in the largest position. Name I dentifier Weight ...
SAN FRANCISCO and BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update.
SAN FRANCISCO and BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update.
NEWTON, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today reported financial results for the full year ended December 31, 2025 and provided a business up...
NEWTON, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today reported financial results for the full year ended December 31, 2025 and provided a business update.
BETHESDA, Md., March 26, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reported financial results for the fourth quarter and year ended December 31, 2025, and provided a corporate update.
BETHESDA, Md., March 26, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reported financial results for the fourth quarter and year ended December 31, 2025, and provided a corporate update.
– Company to pursue Phase 3 development strategy designed to deliver best-in-class efficacy with a high-dose quarterly regimen in broad patient populations in both severe asthma and CRSwNP –
– Company to pursue Phase 3 development strategy designed to deliver best-in-class efficacy with a high-dose quarterly regimen in broad patient populations in both severe asthma and CRSwNP –
Q4 FY26 Net Sales Increased 2.7% to $248.0 million vs. Q4 FY25 FY26 Net Sales Increased 2.4% to $697.1 million vs. FY25 Announces New $40 million Sh are Repurchase Authoriz ation
Q4 FY26 Net Sales Increased 2.7% to $248.0 million vs. Q4 FY25 FY26 Net Sales Increased 2.4% to $697.1 million vs. FY25 Announces New $40 million Sh are Repurchase Authoriz ation
2026-03-26 | ORCL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Oracle Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ORCL | Press Release Stockhouse
2026-03-26 | ORCL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Oracle Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ORCL | Press Release Stockhouse
There's a financial revolution underway. Banks, payment processors, and institutions are shifting transactions and asset ownership onto the blockchain. As a result, the cryptocurrency industry could move from the fringes of traditional finance to being embedded in its very foundations. For long-term investors, that's a move worth paying attention to, particularly if you're looking for cryptos to b...
There's a financial revolution underway. Banks, payment processors, and institutions are shifting transactions and asset ownership onto the blockchain. As a result, the cryptocurrency industry could move from the fringes of traditional finance to being embedded in its very foundations. For long-term investors, that's a move worth paying attention to, particularly if you're looking for cryptos to buy and hold forever. Tokenization, a way to record ownership on the blockchain, is at the core of this dramatic change. Moving assets on-chain can make them more accessible and reduce transfer costs and friction. It can apply to stocks, private equity, U.S. Treasuries, real estate, commodities, and more. Stablecoins, tokenized versions of traditional currencies, soared last year. Here are three cryptocurrencies that could benefit from tokenization, making them strong buys. Continue reading
In this article 6600.T-JP GOOG SSNHZ .FKRX300 Follow your favorite stocks CREATE FREE ACCOUNT Signage outside the Google headquarters in Mountain View, California, US, on Tuesday, Feb. 3, 2026. David Paul Morris | Bloomberg | Getty Images Google's latest research which claims to make AI models more efficient is putting pressure on memory stocks, with investors concerned the breakthrough could see ...
In this article 6600.T-JP GOOG SSNHZ .FKRX300 Follow your favorite stocks CREATE FREE ACCOUNT Signage outside the Google headquarters in Mountain View, California, US, on Tuesday, Feb. 3, 2026. David Paul Morris | Bloomberg | Getty Images Google's latest research which claims to make AI models more efficient is putting pressure on memory stocks, with investors concerned the breakthrough could see a slowdown in chip demand. On Thursday, shares of the world's two biggest memory chipmakers, SK Hynix and Samsung, fell 6% and nearly 5%, respectively in South Korea. Japanese flash memory company Kioxia dropped nearly 6%. These moves followed falls in Sandisk and Micron in the U.S. on Wednesday. Both companies were lower in U.S. premarket trade on Thursday. Alphabet 's Google on Tuesday unveiled TurboQuant , a new compression method that it says could reduce the amount of memory required to run large language models by six times. The technique focuses on reducing the key value cache, which stores the past calculations of an AI model so it doesn't have to run them again. The technique is aimed at making AI models more efficient, a major goal of the leading labs. Investors fear that this could reduce the demand for AI memory chips, which have been a critical component to train up huge LLMs from companies like Google, OpenAI and Anthropic. Matthew Prince, CEO of Cloudflare, called the research "Google's DeepSeek," referencing the efficiency breakthroughs made by Chinese AI firm DeepSeek last year which caused a massive sell-off in tech stocks. "So much more room to optimize AI inference for speed, memory usage, power consumption, and multi-tenant utilization," he said in a post on X on Wednesday. watch now VIDEO 1:42 01:42 Agentic AI deployment and research constrained by chip shortage: Google DeepMind Squawk Box Asia However, Ray Wang, a memory analyst at SemiAnalysis, said that the research from Google won't necessarily lead to the need for fewer chips. The value cache is "...
hapabapa/iStock Editorial via Getty Images Palantir ( PLTR ) and Bain & Company have expanded their lead management consulting partnership to accelerate AI-powered transformations for businesses worldwide. Harnessing Palantir's software and Forward-Deployed Engineers, the expanded pact aims to achieve the end-to-end delivery of AI use cases from strategic plans through to operationalization. The t...
hapabapa/iStock Editorial via Getty Images Palantir ( PLTR ) and Bain & Company have expanded their lead management consulting partnership to accelerate AI-powered transformations for businesses worldwide. Harnessing Palantir's software and Forward-Deployed Engineers, the expanded pact aims to achieve the end-to-end delivery of AI use cases from strategic plans through to operationalization. The two companies first established a global partnership in May last year. Source: Press Release More on Palantir Palantir: Defending Its High-Growth Premium Palantir: This Selloff Is A Gift Palantir: Why I Stay Bullish Despite The Risks Anduril, Palantir work on software for Golden Dome shield - report Enterprise software joins Monday's rally, with Palantir and AppLovin leading